Effect of Pretreatment With Ticagrelor on Residual Thrombus After PCI in Patients Presenting With ACS in Comparison With Delayed Treatment at the Time of PCI: an OCT Study

PHASE4WithdrawnINTERVENTIONAL
0
Timeline

Start Date

February 28, 2014

Primary Completion Date

February 28, 2015

Conditions
Acute Coronary SyndromeCoronary Artery Disease
Interventions
DRUG

Ticagrelor- Delayed Administration

Subjects are randomized to receive ticagrelor immediately after enrollment versus at the time of cardiac catheterization. OCT is performed prior to and after coronary artery stenting.

DRUG

Ticagrelor- Immediate Administration

Subjects are randomized to receive ticagrelor immediately after enrollment versus at the time of cardiac catheterization. OCT is performed prior to and after coronary artery stenting.

PROCEDURE

Optical Coherence Tomography

Trial Locations (1)

02114

Massachusetts General Hospital, Boston

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

AstraZeneca

INDUSTRY

lead

Massachusetts General Hospital

OTHER